Home / News / India News / Article /
Phase II trial of Oxford vaccine candidate to begin in Chandigarh
Updated On: 27 August, 2020 06:08 PM IST | Mumbai | IANS
The prerequisites for the candidates eligibility include a minimum age of 18 years, no underlying medical condition and they should not have contracted Covid-19 already

This picture has been used for representational purpose only
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the first week of September.
The premier institute has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between the Indian Council of Medical Research (ICMR) and Serum Institute of India (SII) within the next two days, Madhu Gupta, principal investigator appointee of the vaccine-trial, told IANS.


